Agilent’s ambitions continue to grow. After a successful 2006 (see IBO 1/15/07), which saw it enter the high-end mass spectrometry (MS) market, the company has set its sights on other market segments. In late March, Agilent announced the formation of a Materials Sciences Solutions Unit (MSSU) within its Life Science and Chemical Analysis (LSCA) business […]
In January, AMETEK formed the Ultra Precision Technologies Division to bring together its Taylor Hobson division with Solartron Metrology and Precitech in order to leverage combined manufacturing operations, technology capabilities and distribution. Symyx Technologies’ 2006 revenues grew 16% to $124.9 million (see page 12), including a 23% increase in Symyx Tools revenues to $37.8 million […]
The South Korean government designated KRW 9.7 trillion ($10.4 billion) for R&D programs this year, an increase of 9.6% from last year. Since 2003, R&D spending has increased an average of 10.6% each year. The government established a science and technology innovation headquarters two years ago, which monitors and seeks to improve the efficiency of […]
This year, IBO’s top 30 analytical and life science instrument companies shifted in rankings and five new companies were added to the list. The top 30 companies accounted for $20.9 billion in sales during 2006, or approximately 64% of the total $32.8 billion analytical and life science instrument market. Twelve of the 30 companies posted […]
According to the Industrial Research Institute’s (IRI) 23rd annual “R&D Trends Forecast,” R&D spending will increase in 2007. IRI’s R&D index is determined by subtracting the percentage of companies that plan to decrease or maintain their R&D spending from the percentage of companies that plan to increase their spending by at least 5%. This index […]
CyBio AG’s 2006 revenues grew 8.2% to €15.5 million ($20.6 million). North American sales increased 18.0% to make up 45.4% of revenues, European sales rose 2.4% to represent 49.7% and Asian sales declined to 4.9% of revenues. Germany accounted for 21.6% of total sales. The instrument business accounted for approximately half of company revenues. In […]
At the beginning of the month, the Science and Technology Facilities Council (STFC) was formed as a merger between the Council for the Central Laboratory of the Research Councils and the Particle Physics and Astronomy Research Council. The STFC hopes to provide strategic leadership and a cohesive approach to UK investments in large national and […]
Dr. Karen A. Holbrook, president of Ohio State University, joined Techne’s board in February. In February, BD Biosciences and Roche announced a collaboration to jointly identify and develop intracellular phosphorylation site antibodies. The companies will develop and validate the antibodies using BD Phosflow technology, and Roche will receive pre-launch access to the antibodies and a […]
This issue, IBO has made two changes to its Lab Equipment/Consumables Sales Index. Merck KGaA was removed from the Index, while Thermo Fisher Scientific’s Laboratory Products and Services segment was added. Fourth quarter sales for the new Lab Equipment/Consumables Index gained 11.9% to $769 million, while operating profits improved 15.5% to $200 million. Operating margin […]
In December 2006, SYSTAG AG, a provider of automated solutions for chemical process development, announced a management buyout of a majority share of the company.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
